← Back to Search

Other

Oxygen Toxicity of HBOT in Chronic Brain Injury

Phase 1
Waitlist Available
Led By Paul G Harch, M.D.
Research Sponsored by Paul G. Harch, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Cerebral disorder of greater than one year's duration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

Hypothesis: That HBOT can be toxic in the low-pressure range.

Eligible Conditions
  • Brain Damage

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hyperbaric oxygen therapyExperimental Treatment1 Intervention
Patients undergoing low pressure HBOT for chronic brain injury
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric oxygen therapy
2013
Completed Phase 3
~1500

Find a Location

Who is running the clinical trial?

Paul G. Harch, M.D.Lead Sponsor
4 Previous Clinical Trials
160 Total Patients Enrolled
Harch Hyperbaric Research FoundationOTHER
3 Previous Clinical Trials
130 Total Patients Enrolled
Paul G Harch, M.D.Principal InvestigatorLSU School of Medicine
4 Previous Clinical Trials
160 Total Patients Enrolled
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top